Pharmacokinetic-pharmacodynamic model for spiramycin in staphylococcal mastitis

Journal of Veterinary Pharmacology and Therapeutics

Volumn 19, Issue 2, 1996, Pages 95-103

  Renard, L ^a   Sanders, P ^a   Laurentie, M ^a   Delmas, J M ^a  

^a Healthy Pigs Production and Experimentation Section   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SPIRAMYCIN;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; CATTLE; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; MASTITIS; MICHAELIS CONSTANT; MODEL; NONHUMAN; POSTANTIBIOTIC EFFECT; PREDICTION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 0029971012     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2885.1996.tb00019.x     Document Type: Article

References (44)

1. Anonymous (1991) Methods for dilution antimicrobial susceptibility. Test for bacteria that grow aerobically. In NCCLS Document M7‐A2. 2nd edn. Eds National Committee for Clinical Laboratory Standards, 10, pp 1–32, American National Standard Institute, Villanova.
2. Brisson‐Noël, A., Treu‐Cuot, P. & Courvalin P. (1988) Mechanism of action of spiramycin and other macrolides. Journal of Antimicrobial Chemotherapy, 22, 13–23.
3. Bundtzen, R. W., Gerber A. U. Cohn, D. L. & Craig, W. A. (1981) Postantibiotic suppression of bacterial growth. Review of Infectious Diseases, 3, 28–37.
4. Carbon, C. (1993) Experimental endocarditis: a review of its relevance to human endocarditis. Journal of Antimicrobial Chemotherapy, 31 Supp D, 71–85.
5. Chabbert, Y. A. (1988) Early studies on in vitro and experimental activity of spiramycin: a review. Journal of Antimicrobial Chemotherapy, 22, 1–11.
6. Chambers, H. F. & Kennedy, S. (1990) Effects of dosage, peak and trough concentrations in serum, protein binding and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis. Antimicrobial Agents and Chemotherapy, 34, 510–514.
7. Cozens, R. M., Tuomanen, E., Tosh, W., Zak, O., Suter, J. & Tomasz, A. (1986) Evaluation of the bactericidal activity of β‐lactam antibiotics on slowly growing bacteria cultured in the chemostat. Antimicrobial Agents and Chemotherapy, 29, 797–802.
8. Drugeon, H. B., Legallou, F. & Caillon, J. (1990) Méthodes d;études de l'activité bactéricide. In Bactéricidie, Eds Courvalin, P., Drugeon, H., Flandrois, J. P. Goldstein, F., pp 113–126. Maloine. Paris.
9. Franklin, A., Horn af Rantzien, M., Obel, N., Ostensson, K. & Astrom, G. (1986) Concentrations of penicillin, streptomycin and spiramycin in bovine udder tissue liquids. American Journal of Veterinary Research, 47, 804–807.
10. Garret, E. R. (1978) Kinetics of antimicrobial action. Scandinavian Journal of Infectious Disease, 14, 54–85.
11. Gengo, F. M., Mannion, T. W., Nightingale, C. H. & Schentag, J. J. (1984) Integration of pharmacokinetics and pharmacodynamics of methicillin in curative treatment of experimental endocarditis Journal of Antimicrobial Chemotherapy, 14, 619–631.
12. Gerber, A. U., Feller, C. & Brugger, H. P. (1984) Time course of pharmacological response to β‐lactam antibiotics in vitro and in vivo. European Journal of Microbiology, 3, 592–597.
13. Gibaldi, M. & Perrier, D. (1975) Bioavailability. Trapezoidal rule. In Pharmacokinetics. pp 129–166. 293–296. 1st edn. Marcel Dekker, New York.
14. Holford, N. H. G. & Sheiner, L. B. (1981) Understanding the dose‐effect relationship: Clinical applications of the PK/PD models. Clinical Pharmacokinetics, 6, 429–453.
15. Hoojeterp, J. J., Mattie, H. & van Furth, R. (1993) Activity of erythromycin and clindamycin in experimental staphylococcus infection in normal and granulopenic mice. Scandinavian Journal of Infectious Disease, 25. 123–132.
16. Koritz, G. D. & Bevill, R. F. (1991) Role of pharmacokinetics in the outcome of infections. Proceedings of 5th Congress of EAVPT, Copenhagen. Acta Veterinaria Scandinavica, Supp 87. 18–27.
17. Mattie, H. (1981) Kinetics of antimicrobial action. Review of Infectious Disease, 3, 19–27.
18. Mattie, H. Dokkum, A. M., Brus‐Weijer, L., Krul A. M. & Strijen, E. (1990) Antibacterial activity of four cephalosporins in an experimental infection in relation to in vitro effect and pharmacokinetics. Journal of Infectious Disease, 162, 717–722.
19. Odenholt‐Tornqvist I. (1989) Studies on the paradoxal and postantibiotic effects in vitro and in an animal model. Scandinavian Journal of Infectiuos Disease, 58, 1–55.
20. Paape, M. J., Miller, R. H. & Ziv, G. (1991) Pharmacologic enhancement or suppression of phagocytosis by bovine neutrophils. American Journal of Veterinary Research, 52, 363–366.
21. Peck, C. C., Barr W. H., Benet, L. Z., Collins, J. Desjardins R. E., Furst, D. E., Harter, J. G., Levy, G., Ludden, T., Rodman, J. H., Sanathanan, L. Schentag J. J., Shah, V. P., Sheiner, L. B. Skelly J. P., Stanki, D. R., Temple, R. J. Viswanathan C. T., Weissinger, J. & Yacobi, A. (1992) Opportunities for integration of pharmacokinetics pharmacodynamics and toxicokinetics in rational drug development. International Journal of Pharmacy, 82, 9–19.
22. Peetermans, W. E., Hoojeterp, J. J., Hazekamp‐van Dokkum, A. M., van Den Broek, P. & Mattie, H. (1990) Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection. Antimicrobial Agents and Chemotherapy. 34, 1869–1874.
23. Petitjean, O., Tod, M. & Nicolas, P. (1990) Conséquences de la bactéricidie sur les schémas thérapeutiques. In Bactéricidie. Eds Courvalin P., Drugeon, H., Flandrois, J. P. Goldstein F. pp 275–312, Maloine, Paris.
24. Polonovski M., Boulanger, P., Machebeouf, M. & Roche, J. (1973) Les. In Médicale, 10th edn. Eds Boulanger, P. F., Mandel, P. & Biserte, G. pp 1–58, Masson.
25. Ram M. & Poutrel, B. (1978) Induced staphyloccoccal in the bovine mammary gland. American Journal of 39, 29–35.
26. Legallou, F., Bugnon, D., Le Conte, P., Raza, J., Lepage, M. Drugeon, H. (1992) Identification of factors affecting activity in an experimental model of gram‐negative Agents and Chemotherapy, 36, 744–750.
27. Induced staphylococcal infections in the bovine Annales de Recherches Vétérinaires, 47, 155–164.
28. Sanders, P. & Laurentie, M., (1993) Modélisation de l'effet spiramycine. Choix d'un modéle pharmacodynami. 24, 33–45.
29. Sanders, P., Laurentie, M. & Delmas, J. M. (1994) Neospiramycin in plasma and milk of reversed‐phase high‐performance liquid chromato‐ B. 657, 219–226.
30. Sanders, J. M., Girard, D., Milisen, W. B. & Girard, A. E. Concentration of azithromycin in infected mouse Antimicrobial Chemotherapy, 31, 5–16.
31. Sanders, D. H. (1989) Comparaison de l'effet post de macrolides en C14 (érythromycin and et spiramycine) vis‐á‐vis de Logie Biologie, 37, 375–377.
32. Gaudiche, C., Delépine, B. & Mourot, D. (1991) Liquid chromatographic and bioassay spiramycin concentration in bovine plasma. 74, 912–917.
33. Guillot, P., Dagorn, M., Perjant, P., Delépine, B. D., (1992) Pharmacokinetics of spiramycin and subcutaneous administration of Pharmacology and Theraputics, 15,.
34. Sandholm, M., Kaartinen, L. & Pyörálá, S. (1990) Bovine mastitis‐why does antibiotic therapy not always work? An overview. Journal of Veterinary Pharmacology and Therapeutics, 13, 248–260.
35. Schällibaum, J., Nicolet, J. & Bosson, J. (1981) Die behandlung von chronisch‐subklinischen staphylokokenmastitiden beim laktierenden rind durch die verabreichnung von hohen spiramycindosen. Schweizer Archiv fur Tierheilkunde, 123, 277–292.
36. Schmidt, T. & Taüber, M. G. (1993) Pharmacodynamics of antibiotics in the therapy of meningitis: infection model observations. Journal of Antimicrobial Chemotherapy, 31 Suppl D, 61–70.
37. Sears, P. M., Smith, B. S., English, P. B., Herer, P. S. & Gonzalez, R. N. (1991) Microbiological results from milk samples obtained premilking and postmilking for the diagnosis of bovine intramammary infections. Journal of Dairy Science, 73, 2785–2789.
38. Videau, D. (1978) La spiramycine: bacteriologie, pharmacologie, pharmacocinétique et distribution tissulaire. Cahier de Médecine Vétérinaire, 47, 155–164.
39. Vogelman, B. & Craig, A. W. (1986) Kinetics of antimicrobial activity. Journal of Pediatry, 108, 835–840.
40. Vogelman, B. & Craig, W. A. (1985) Postantibiotic effects. Journal of Antimicrobial Chemotherapy, 15, 37–46.
41. Watanabe, Y. & Craig, W. (1992) Bactericidal effect of antibiotics on non‐growing intracellular staphylococcus aureus (SA) in human pneumocytes. In Program and Abstracts of the 32 Interscience conference on antimicrobial and chemotherapy. Abstract 47. American society for microbiology, Washington DC.
42. Wilson J. T. (1983) Determinants and consequence of drug excretion in breast milk. Drug Metabolism Review, 14, 619–652.
43. Yamaoka, K. & Nakagawa, T. (1983) A nonlinear least squares program based on differential equations, multi(range) for microcomputers. Journal of Pharmacobio-Dynamics, 6, 595–606.
44. Zhi, J., Nightingale, C. H. & Quintiliani, R. (1986) A pharmacodynamic model for the activity of antibiotics against micro‐organisms under non saturable conditions. Journal of Pharmaceutical Sciences, 75, 1063–1067.